Combining biostatistical analyses and wet-lab experiments, the aim of this study was to explore SPINK1, a potentially qualified candidate, as a better marker for the early diagnosis, molecular targeting, and the prediction of the response to ICB treatment of HCC. The gene discussed is SPINK1; the disease is hepatocellular carcinoma.